American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 12(65), 2021
DOI: 10.1128/aac.01121-21
Full text: Download
Increasing resistance in Plasmodium falciparum to artemisinins and their artemisinin combination therapy (ACT) partner drugs jeopardizes effective antimalarial treatment. Resistance is worst in the Greater Mekong subregion.